Skip to main content
Clinical Trials/NCT06111430
NCT06111430
Recruiting
Not Applicable

The Ambidirectional Cohort Study of Neurovascular Complications After Radiation Therapy in Head and Neck Cancer Patients

Chang Gung Memorial Hospital1 site in 1 country800 target enrollmentApril 11, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Radiation Treatment
Sponsor
Chang Gung Memorial Hospital
Enrollment
800
Locations
1
Primary Endpoint
Significant intracranial artery stenosis
Status
Recruiting
Last Updated
last month

Overview

Brief Summary

Head and neck cancer is a group of cancers develop from the soft tissues, salivary gland, mucosa of the upper respiratory or digestive system covering the oral and nasal cavity. Radiotherapy is usually the standard treatment of Head and neck cancers. In the present study, investigators aim to study the prevalence of cervical-cranial vascular complications during the early stages in these Head and neck cancer patients receiving Radiotherapy. Investigators will also compare the results between Nasopharyngeal cancer and other Head and neck cancerpatients receiving Radiotherapy.

Registry
clinicaltrials.gov
Start Date
April 11, 2022
End Date
April 10, 2026
Last Updated
last month
Study Type
Observational
Sex
All

Investigators

Sponsor
Chang Gung Memorial Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Population: Prospective cohort
  • Inclusion Criteria:
  • Age ≥20 years.
  • Head and neck cancer patient .
  • Had ever received radiation therapy (RT) ≦ 72 months before inclusion in the registry.
  • Had ≥ 1 brain images and cervical-cranial vascular studies between the end of RT and d date of enrolment.

Exclusion Criteria

  • Age \<20 years.
  • Patients not willing to sign the informed consent.
  • Population: Retrospective validation cohort
  • Inclusion Criteria:
  • Age ≥20 years.
  • Head and neck cancer patient.
  • Had ever received radiation therapy (RT) \> 120 months before the adoption date of IRB at the participant site.
  • Had ≥ 2 brain images and cervical-cranial vascular studies between the end of RT and 6\~10 years after RT, one within 5 years after RT, the other after 5 years after RT.
  • Exclusion Criteria:
  • 1.Age \<20 years.

Outcomes

Primary Outcomes

Significant intracranial artery stenosis

Time Frame: 1 year

Presence of \> 50% stenosis at intracranial ICA/VA, basilar artery, middle cerebral artery, anterior cerebral artery, or anterior cerebral artery.

Presence of carotid blow-out syndrome

Time Frame: 1 year

Carotid blow out syndrome was categorized as type 1 (threaten type), type 2 (impending blowouts), and type 3 (acute CBS hemorrhage).

Presence of hypothyroidism

Time Frame: 1 year

Clinical hypothyroidism was diagnosed when a patient had free T4 ≤ 0.80 ng/dL with elevated TSH (\>5.0 mU/L).

Significant CAS at internal carotid artery or common carotid artery

Time Frame: 1 year

We define significant CAS as (a) \>50% stenosis on the B-mode with peak systolic velocities ≥120 cm/s based on the hemodynamic criteria at any internal carotid artery or common carotid artery in the CDU study according to the standard ultrasound criteria35; or (b) \> 50% diameter stenosis on the follow up CT or MR images.

Cerebral infarctions (CI)

Time Frame: 1 year

The CI is defined whenever there were symptomatic IS occurrence of presence of asymptomatic IS on the reviewed brain MRIs.

Significant extracranial vertebral artery stenosis (VAS)

Time Frame: 1 year

\> 50% diameter stenosis on the follow up CT or MR images.

Presence of TLN

Time Frame: 1 year

We will identify white matter lesions, contrast-enhanced lesions, Cysts, and local mass effect. The white matter lesions in the temporal lobe will be divided into three groups: mild (small focal areas), moderate (larger confluent areas) and severe (large confluent areas extending outside the radiation field with or without local mass effect). The cysts will be evaluated for size and number. The local mass effect will be classified as mild (affecting only the temporal lobe sulci), moderate (affecting the sulci and ventricles) and severe (affecting the midline of the brain).

Tumor recurrence

Time Frame: 1 year

Relapse

Mortality

Time Frame: 1 year

Death

Study Sites (1)

Loading locations...

Similar Trials